One of the big healthcare related news stories this month was the announcement by CVS Caremark that it was going to stop selling cigarettes and all other tobacco products in its stores.
As the country’s largest drugstore chain in terms of overall sales, second only to Walgreen’s in number of stores, the announcement made headlines across the nation. The decision will cost the company an estimated $2 billion in annual sales, a loss the company is willing to take to strengthen its brand as a health care provider and not just a retail business.
In this video, Dr. Dan Raz, assistant professor and Co-director of the Lung Cancer and Thoracic Oncology Program, and Director of the Tobacco Exposure Program at City of Hope, discusses the barriers many individuals, especially Hispanics, face with regards to lung cancer screening.
E-cigarettes seem to be everywhere these days. You’ve probably noticed Vapor stores popping up on street corners and in strip malls, advertisements and celebrity endorsements. While cities like L.A. have started banning e-cigarettes in workplaces and public spaces, it comes after explosive growth and popularity. Within three years of entering the marketplace in 2007, Bloomberg reports that e-cigarettes had grown to a $1.5 billion industry. Between 2010 and 2011, the market continued to escalate as the number of smokers trying e-cigarettes doubled, according to the CDC, from 10% to 21%.